European Patent Issued for Human and Pet Anti-Obesity Vaccine to Braasch Biotech

European Patent Issued for Human and Pet Anti-Obesity Vaccine to Braasch Biotech

European Patent issued in the United Kingdom for anti-obesity vaccine technologies. Applications for human and pet therapeutic vaccines to treat adult onset obesity. - July 14, 2017

South Korea Patent Allowance for Anti-Obesity Pet Vaccines to Braasch Biotech LLC

Braasch Biotech granted Anti-Obesity patent for pets by Korean Intellectual Property Office. Commercial utility and novelty for first therapeutic vaccine for use in obese dogs, cats and horses. - June 11, 2016

Asian Patent Acceptances Enhance Braasch Biotech Livestock Portfolio

New paradigm of using vaccines to enhance productivity in livestock, Braasch Biotech continues portfolio expansion - January 21, 2016

Israel Patent Allowance for GH, IGF-1 and Obesity Vaccines to Braasch Biotech

Israel Patent Allowance for GH, IGF-1 and Obesity Vaccines to Braasch Biotech

Israel Patent Office allows patent for treatment of hormone deficiencies and obesity in humans and pets. - August 01, 2015

China Patent for Therapeutic Vaccine Treatment of Obesity to be Granted to Braasch Biotech

China Patent for Therapeutic Vaccine Treatment of Obesity to be Granted to Braasch Biotech

China's State Intellectual Property Office to grant Braasch Biotech's patent on Therapeutic treatment of human and pet obesity. - March 13, 2015

Braasch Biotech Bolsters Intellectual Property with Patent Acceptance in the Philippines

Braasch Biotech LLC continues patent portfolio expansion with new issue in the Philippines. Novel technologies allow safe enhancement of livestock productivity by use of vaccination rather than exogenous pharmaceuticals. - January 15, 2015

Braasch Biotech to Participate at Informa's 9th Annual Veterinary Vaccine Conference

Braasch's Biotech's Dr. Keith Haffer to host seminar on adjuvants at Informa's Veterinary Vaccine Conference in December. - August 25, 2014

Press Releases 1 - 7 of 7